Schlagwort: company building
The Biotech IP Flip: Scaling Up Instead of Selling
Many European biotech companies still view the U.S. market primarily as a future exit channel. Yet it can be leveraged much earlier - not...
“I saved the best I have for you”
Together with the investor Kleiner Perkins, Origenis GmbH founded the company Neuron23 in the US in 2018. How did this come about and how...

